Establishment and Function Sample Clauses

The 'Establishment and Function' clause defines the creation and operational purpose of a particular entity, body, or committee within an agreement. It typically outlines how the entity is formed, who its members are, and what specific roles or responsibilities it will undertake. For example, it may specify the formation of a project steering committee, detail its decision-making authority, and describe its meeting procedures. This clause ensures that all parties have a clear understanding of the existence, structure, and duties of the entity, thereby promoting effective governance and coordination throughout the duration of the agreement.
Establishment and Function. The Employer and the Union shall establish a Bargaining Committee whose function shall be to deal with all matters pertaining to rates of pay, hours of work and other working conditions applicable to employees in the Bargaining Unit.
View SourceView Similar (12)
Establishment and Function. (a) The parties confirm that the Joint Steering Committee established under the Initial Licence will be and become the Joint Steering Committee under this Agreement (“JSC”). (b) Each party will retain the rights, powers and discretion granted to it under this Agreement and no such rights, powers or discretion will be delegated or vested in the JSC unless such delegation or vesting of rights is expressly provided for in this Agreement or the parties expressly agree to such delegation or vesting of rights in writing. (c) The JSC will only have the powers expressly assigned to the JSC by this Agreement, and will not have any power to amend, modify or waive compliance with this Agreement. (d) Without limiting clause 5.1(c), and except as otherwise provided in clause 5.1(e)(iii) and clause 5.6, the JSC’s powers in respect of NNZ-2591 Compound or NNZ‑2591 Product will only be in respect of any activities related solely to NNZ‑2591 Compound or NNZ‑2591 Product in the NNZ‑2591 Field in the applicable Territory and the JSC will not have any power over any activities in respect of NNZ‑2591 Compound or NNZ‑2591 Product which do not relate solely to the NNZ‑2591 Field in the applicable Territory. (e) The JSC will perform the following functions: (i) acting as the governing body of the JV; (ii) remaining informed of the development and contents of all material regulatory submissions to Government Agencies for any Compound or Product in the applicable Field and Territory for Marketing Authorisations and all necessary filing and registration activities related to Marketing Authorisations for any Compound or Product in the applicable Field and applicable Territory; (iii) subject to the information-sharing obligations set forth in clause 5.6, serve as a forum for consideration of and exchanging data and results generated by each party relating to any NNZ-2591 Compound or NNZ-2591 Product in and outside the applicable Field and applicable Territory; (iv) review the development plans prepared by ACADIA in accordance with clause 6.1(b) and any updates to them; (v) review and approve (if appropriate) any Proposal to develop the Trofinetide Compound for use in an indication other than Rett Syndrome and Fragile X Syndrome in accordance with clause 6.2; (vi) subject to the information-sharing obligations set forth in clause 5.6 and clause 7.2, responsibility for monitoring and reviewing each party’s Regulatory, manufacturing, CMC, Development or Commercialization activities in re...
View Source
Establishment and Function. The Parties shall establish a Joint -------------------------- Marketing Committee (the "JMC") with respect to each Potential Co-Promotion Product within thirty (30) days after the Completion of Pivotal Clinical Trials for such Potential Co-Promotion Product. The purpose of the JMC shall be to (i) oversee the Commercialization of Potential Co-Promotion Products and Co- Promotion Products in the Co-Promotion Territory, including the annual budgeting and forecasting, commercial manufacturing, marketing, sales and distribution of Potential Co-Promotion Products and Co-Promotion Products, (ii) monitor, review and comment on costs incurred by the Parties in the commercial manufacture, marketing, sale and distribution of Potential Co-Promotion Products and Co- Promotion Products in the Co-Promotion Territory, (iii) review and comment on the Commercialization Plans for Potential Co-Promotion Products and Co-Promotion Products in the Co-Promotion Territory, (iv) receive and provide to the Parties all sales, pricing, and financial reports pertaining to Commercialization of Potential Co-Promotion Products and Co-Promotion Products, (v) review and comment on SCHERING's pricing recommendations for Potential Co-Promotion Products and Co-Promotion Products in the Co-Promotion Territory, (vi) budget annually (and update appropriately) each Party's expected Detailing effort for each calendar year, and (vi) facilitate the flow of information with respect to the Commercialization of each Potential Co-Promotion Products and Co-Promotion Product. The JMC shall not be involved with the commercialization of Royalty Bearing Products, MYRIAD Products or Diagnostic Products
View Source
Establishment and Function. Within thirty (30) days after -------------------------- SCHERING shall have exercised its first Exclusive Pathway Option, SCHERING and MYRIAD shall establish a Drug Development and Management Committee (the "DDMC"). The DDMC shall plan, administer and monitor the Drug Discovery and Early Development Program with respect to Genes and Interactive Proteins within such Pathway and each subsequent Pathway with respect to which SCHERING shall have exercised an Exclusive Pathway Option.
View Source
Establishment and Function. Within 30 days after the Effective Date, the Parties shall establish an advisory council (as described in this Section 3.1(f), the “Advisory Council”) for the purpose of communication and consultation regarding the Development of the Compound and Product, including review and discussion of the Development Plan and amendments thereto and discussion of either Party’s concerns regarding the other Party’s performance of its responsibilities hereunder. Without limiting the foregoing, the Advisory Council shall discuss development strategies and opportunities of the Compound using both lutetium and actinium.
View Source

Related to Establishment and Function

  • MANAGEMENT FUNCTIONS B.1 The Association recognizes that the management of the Hospital and the direction of working forces are fixed exclusively in the Hospital and shall remain solely with the Hospital except as specifically limited by the provisions of this Agreement and, without restricting the generality of the foregoing, the Association acknowledges that it is the exclusive function of the Hospital to: (a) maintain order, discipline and efficiency; (b) hire, assign, retire, discharge, direct, promote, demote, classify, transfer, lay- off, recall, and suspend or otherwise discipline nurses, provided that a claim of discharge or discipline without just cause may be the subject of a grievance and dealt with as hereinafter provided; (c) determine, in the interest of efficient operation and high standards of service, job rating and classification, the hours of work, work assignments, methods of doing the work, and the working establishment for the service; (d) generally to manage the operation that the Hospital is engaged in and, without restricting the generality of the foregoing, to determine the number of personnel required, methods, procedures, and equipment in connection therewith; (e) make, enforce, and alter from time to time reasonable rules and regulations to be observed by the nurses which are not inconsistent with the provisions of this Agreement. B.2 These rights shall not be exercised in a manner inconsistent with the provisions of this Agreement.

  • Duties and functions 23.2.1 The Independent Engineer shall discharge its duties and functions substantially in accordance with the terms of reference set forth in Schedule 16. 23.2.2 The Independent Engineer shall submit regular periodic reports (at least once every month) to the Authority in respect of its duties and functions set forth in Schedule 16.

  • Additional Functions Upon receipt of Proper Instructions, the Custodian shall take all such other actions as specified in such Proper Instructions and as shall be reasonable or necessary with respect to Repurchase Agreement transactions and the Securities and funds transferred and received pursuant to such transactions, including, without limitation, all such actions as shall be prescribed in the event of a default under a Repurchase Agreement.

  • MIXED FUNCTIONS An employee engaged for more than two hours during one day or shift on duties carrying a higher rate than his or her ordinary classification shall be paid the higher rate for such day or shift. If for two hours or less during one day or shift he or she shall be paid the higher rate for the time so worked.

  • Money Market Fund Compliance Testing and Reporting Services Subject to the authorization and direction of the Trust and, in each case where appropriate, the review and comment by the Trust’s independent accountants and legal counsel, and in accordance with procedures that may be established from time to time between the Trust and the Administrator, the Administrator will: